The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Absolute Assignment of Breast Cancer Intrinsic Molecular Subtype
Abstract
BACKGROUND: Massively parallel gene expression profiling has provided a more objective, molecular-level characterization of breast cancer subtypes. Several bioinformatics tools are available to infer patient subtype from a gene expression profile including the well-studied PAM50. The specific algorithmic methods used in these tools require access to a broad patient dataset. The choice of subtype for an individual is determined relative to all other patients across the panel, making subtypes heavily dependent on the composition of the dataset. Our aim was to develop a bioinformatics approach assigning absolute breast cancer subtypes, independent of dataset composition. METHODS: Using a dataset of 4924 breast cancer patients, we defined a new bioinformatics approach: Absolute Intrinsic Molecular Subtyping (AIMS) that assigns subtype from a gene expression profile for an individual sample without the need for a large, diverse, and normalized dataset. We evaluated the agreement of AIMS with PAM50 and compared subtype assignment and prognostic value of the subtypes. We assessed AIMS' robustness using a benchmark set of tests including subtype reproducibility between technologies, gene removal, and normal gene expression contamination, and compared it with PAM50. All statistical tests, except where noted, were two-sided. RESULTS: AIMS vastly agreed with PAM50, with 76% and 77% agreement for cross validation and the test set, respectively, and the prognostic capacity of the intrinsic subtypes was preserved. AIMS is fully stable, and its absolute nature enables its use on a wide range of datasets and technologies, including RNA-seq. CONCLUSIONS: The instability of a breast cancer subtyping scheme like PAM50 could have important consequences in clinical management of patients. AIMS is a fully stable and robust subtyping scheme that recapitulates PAM50.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Bullard, J. H., Purdom, E., Hansen, K. D., & Dudoit, S. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-94 · Cited by 1,680
A comparison of background correction methods for two-colour microarrays
Ritchie, M. E., Silver, J., Oshlack, A., Holmes, M., Diyagama, D., Holloway, A., & Smyth, G. K. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm412 · Cited by 907
Research works printed but not linked: 35
- Perou, 2000, Molecular portraits of human breast tumours, Nature, 406, 747, 10.1038/35021093 · DOI · Paper page
- Sorlie, 2001, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc Natl Acad Sci U S A, 98, 10869, 10.1073/pnas.191367098 · DOI · Paper page
- Weigelt, 2010, The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade, J Pathol, 220, 263, 10.1002/path.2648 · DOI · Paper page
- Gruvberger, 2001, Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns, Cancer Res, 61, 5979
- Pusztai, 2003, Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors, Clin Cancer Res, 9, 2406
- Goldhirsch, 2011, Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011, Ann Oncol, 22, 1736, 10.1093/annonc/mdr304 · DOI · Paper page
- Harbeck, 2013, Molecular and protein markers for clinical decision making in breast cancer: Today and tomorrow, Cancer Treat Rev, 40, 434, 10.1016/j.ctrv.2013.09.014 · DOI
- Guedj, 2012, A refined molecular taxonomy of breast cancer, Oncogene, 31, 1196, 10.1038/onc.2011.301 · DOI · Paper page
- Lehmann, 2011, Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies, J Clin Invest, 121, 2750, 10.1172/JCI45014 · DOI · Paper page
- Jonsson, 2010, Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics, Breast Cancer Res, 12, R42, 10.1186/bcr2596 · DOI · Paper page
- Lusa, 2007, Challenges in projecting clustering results across gene expression-profiling datasets, J Natl Cancer Inst, 99, 1715, 10.1093/jnci/djm216 · DOI
- Sorlie, 2010, The importance of gene-centring microarray data, Lancet Oncol, 11, 719, 10.1016/S1470-2045(10)70174-1 · DOI
- Weigelt, 2010, Breast cancer molecular profiling with single sample predictors: a retrospective analysis, Lancet Oncol, 11, 339, 10.1016/S1470-2045(10)70008-5 · DOI · Paper page
- Perou, 2010, Clinical implementation of the intrinsic subtypes of breast cancer, Lancet Oncol, 11, 718, 10.1016/S1470-2045(10)70176-5 · DOI
- Gautier, 2004, affy--analysis of Affymetrix GeneChip data at the probe level, Bioinformatics, 20, 307, 10.1093/bioinformatics/btg405 · DOI · Paper page
- Parker, 2009, Supervised risk predictor of breast cancer based on intrinsic subtypes, J Clin Oncol, 27, 1160, 10.1200/JCO.2008.18.1370 · DOI · Paper page
- Tofigh, 2014, The prognostic ease and difficulty of invasive breast carcinoma, Cell Reports, 9, 129, 10.1016/j.celrep.2014.08.073 · DOI
- Prat, 2014, Research-based PAM50 subtype predictor identifies higher responses and improved survival outcomes in HER2-positive breast cancer in the NOAH study, Clin Cancer Res, 20, 511, 10.1158/1078-0432.CCR-13-0239 · DOI · Paper page
- Hu, 2006, The molecular portraits of breast tumors are conserved across microarray platforms, BMC Genomics, 96, 10.1186/1471-2164-7-96 · DOI · Paper page
- Desmedt, 2008, Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes, Clin Cancer Res, 14, 5158, 10.1158/1078-0432.CCR-07-4756 · DOI · Paper page
- Wirapati, 2008, Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures, Breast Cancer Res, 10, R65, 10.1186/bcr2124 · DOI · Paper page
- Haibe-Kains, 2012, A three-gene model to robustly identify breast cancer molecular subtypes, J Natl Cancer Inst, 104, 311, 10.1093/jnci/djr545 · DOI · Paper page
- Tan, 2005, Simple decision rules for classifying human cancers from gene expression profiles, Bioinformatics, 21, 3896, 10.1093/bioinformatics/bti631 · DOI · Paper page
- Elloumi, 2011, Systematic bias in genomic classification due to contaminating non-neoplastic tissue in breast tumor samples, BMC Med Genomics, 4, 54, 10.1186/1755-8794-4-54 · DOI
- Hoffman, 2010, CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses, Cancer Res, 70, 1459, 10.1158/0008-5472.CAN-09-3798 · DOI · Paper page
- Lee, 2011, Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women, J Clin Oncol, 29, 4373, 10.1200/JCO.2010.33.6446 · DOI
- Stead, 2009, Triple-negative breast cancers are increased in black women regardless of age or body mass index, Breast Cancer Res, 11, R18, 10.1186/bcr2242 · DOI · Paper page
- Cicatiello, 2010, Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs, Am J Pathol, 176, 2113, 10.2353/ajpath.2010.090837 · DOI · Paper page
- Wen, 2011, Discovery of molecular mechanisms of traditional Chinese medicinal formula Si-Wu-Tang using gene expression microarray and connectivity map, PLoS ONE, 6, e18278, 10.1371/journal.pone.0018278 · DOI
- Dowsett, 2013, Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy, J Clin Oncol, 31, 2783, 10.1200/JCO.2012.46.1558 · DOI · Paper page
- Lu, 2008, Predicting features of breast cancer with gene expression patterns, Breast Cancer Res Treat, 108, 191, 10.1007/s10549-007-9596-6 · DOI · Paper page
- Li, 2010, Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer, Nat Med, 16, 214, 10.1038/nm.2090 · DOI · Paper page
- Loi, 2007, Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade, J Clin Oncol, 25, 1239, 10.1200/JCO.2006.07.1522 · DOI · Paper page
- Miller, 2005, An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival, Proc Natl Acad Sci U S A, 102, 13550, 10.1073/pnas.0506230102 · DOI · Paper page
- Pawitan, 2005, Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts, Breast Cancer Res, 7, R953, 10.1186/bcr1325 · DOI · Paper page
Cited by
CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers
Bill, R., Wirapati, P., Messemaker, M., Roh, W., Zitti, B., Duval, F., Kiss, M., Park, J. C., Saal, T. M., Hoelzl, J., et al. (2023) · Science · doi:10.1126/science.ade2292 · Cited by 663
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
Wallden, B., Storhoff, J., Nielsen, T., Dowidar, N., Schaper, C., Ferree, S., Liu, S., Leung, S., Geiss, G., Snider, J., et al. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0129-6 · Cited by 542
Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
Staaf, J., Glodzik, D., Bosch, A., Vallon-Christersson, J., Reuterswärd, C., Häkkinen, J., Degasperi, A., Amarante, T. D., Saal, L. H., Hegardt, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0582-4 · Cited by 307
Chopra, N., Tovey, H., Pearson, A., Cutts, R., Toms, C., Proszek, P., Hubank, M., Dowsett, M., Dodson, A., Daley, F., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16142-7 · Cited by 259
Brufsky, A., Kim, S. B., Zvirbule, Ž., Eniu, A., Mebis, J., Sohn, J. H., Wongchenko, M., Chohan, S., Amin, R., Yan, Y., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.01.065 · Cited by 92
Metadata
- Authors
- Paquet, E. R., & Hallett, M. T.
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-12-04
- Volume
- 107
- Issue
- 1
- Pages
- 357-357
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2157168213
- Cited by
- 186
- References
- 4
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Absolute Assignment of Breast Cancer Intrinsic Molecular Subtype. https://app.cochat.ai/papers/10.1093/jnci/dju357
- The paper
- Paquet, E. R., & Hallett, M. T. (2015). Absolute Assignment of Breast Cancer Intrinsic Molecular Subtype. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/dju357
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.